For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) closed the day trading at $0.59 up 0.56% from the previous closing price of $0.59. In other words, the price has increased by $0.56 from its previous closing price. On the day, 1.64 million shares were traded. PCSA stock price reached its highest trading level at $0.63 during the session, while it also had its lowest trading level at $0.542.
Ratios:
For a better understanding of PCSA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.97 and its Current Ratio is at 3.97. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 25, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 27 ’25 when Ng George K bought 87,200 shares for $0.80 per share. The transaction valued at 69,542 led to the insider holds 87,200 shares of the business.
Young David bought 124,500 shares of PCSA for $99,289 on Jan 27 ’25. The Pres. Research & Development now owns 205,405 shares after completing the transaction at $0.80 per share. On Jan 27 ’25, another insider, Lin Patrick, who serves as the Chief Business – Strategy Off of the company, bought 43,500 shares for $0.80 each. As a result, the insider paid 34,691 and bolstered with 43,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 2193067 and an Enterprise Value of -859609.
Stock Price History:
The Beta on a monthly basis for PCSA is 0.54, which has changed by -0.7482906 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, PCSA has reached a high of $3.31, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is -36.46%, while the 200-Day Moving Average is calculated to be -59.01%.
Shares Statistics:
Over the past 3-months, PCSA traded about 345.07K shares per day on average, while over the past 10 days, PCSA traded about 85600 shares per day. A total of 3.71M shares are outstanding, with a floating share count of 3.34M. Insiders hold about 10.01% of the company’s shares, while institutions hold 1.58% stake in the company. Shares short for PCSA as of 1736899200 were 86361 with a Short Ratio of 0.25, compared to 1734048000 on 333242. Therefore, it implies a Short% of Shares Outstanding of 86361 and a Short% of Float of 2.53.